Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (508)
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
545
Price
$1.54
Total Value
$839.30
Shares Held After
718,989
% of Holdings
0.1%
Pyxis Oncology, Inc. (PYXS)
Dupont Jakob — Director
Shares
35,000
Price
$3.06
Total Value
$107.10K
Shares Held After
38,741
% of Holdings
47.5%
ABEONA THERAPEUTICS INC. (ABEO)
Alland Leila — Director
Shares
11,000
Price
$5.92
Total Value
$65.09K
Shares Held After
162,614
% of Holdings
6.3%
CERUS CORP (CERS)
Greenman William Mariner — Director
Shares
101,919
Price
$2.94
Total Value
$299.94K
Shares Held After
5,053,036
% of Holdings
2.0%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
5,681
Price
$70.00
Total Value
$397.67K
Shares Held After
9,756
% of Holdings
36.8%
CERUS CORP (CERS)
Jayaraman Vivek K — Chief Operating Officer
Shares
42,359
Price
$2.94
Total Value
$124.66K
Shares Held After
1,694,348
% of Holdings
2.4%
CERUS CORP (CERS)
Jensen Chrystal — Chief Legal Officer
Shares
24,329
Price
$2.94
Total Value
$71.60K
Shares Held After
966,657
% of Holdings
2.5%
CERUS CORP (CERS)
Green Kevin Dennis — Chief Financial Officer
Shares
33,676
Price
$2.94
Total Value
$99.11K
Shares Held After
1,062,188
% of Holdings
3.1%
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
Christianson Mark — Market Development Director
Shares
10,000
Price
$3.18
Total Value
$31.77K
Shares Held After
20,692
% of Holdings
32.6%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
3,200
Price
$117.70
Total Value
$376.65K
Shares Held After
244,883
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
6,153
Price
$116.99
Total Value
$719.86K
Shares Held After
248,083
% of Holdings
2.4%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
7,971
Price
$115.82
Total Value
$923.18K
Shares Held After
254,236
% of Holdings
3.0%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
51,375
Price
$114.77
Total Value
$5.90M
Shares Held After
262,207
% of Holdings
16.4%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
4,110
Price
$114.19
Total Value
$469.31K
Shares Held After
313,582
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,100
Price
$112.79
Total Value
$124.07K
Shares Held After
317,692
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,700
Price
$111.57
Total Value
$189.66K
Shares Held After
318,792
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,500
Price
$110.54
Total Value
$165.81K
Shares Held After
320,492
% of Holdings
0.5%
Dogecoin Cash, Inc. (CBDS)
TOBIAS DAVID — Director
Shares
150,000
Price
$0.01
Total Value
$1.27K
Shares Held After
24,143,200
% of Holdings
0.6%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
28,826
Price
$16.04
Total Value
$462.29K
Shares Held After
139,372
% of Holdings
17.1%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
115,844
Price
$45.50
Total Value
$5.27M
Shares Held After
2,555,877
% of Holdings
4.3%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
115,844
Price
$45.50
Total Value
$5.27M
Shares Held After
2,555,877
% of Holdings
4.3%
uniQure N.V. (QURE)
Kaye Jack — Director
Shares
17,060
Price
$46.43
Total Value
$792.10K
Shares Held After
25,996
% of Holdings
39.6%
uniQure N.V. (QURE)
Kaye Jack — Director
Shares
4,107
Price
$46.49
Total Value
$190.93K
Shares Held After
25,996
% of Holdings
13.6%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
20,000
Price
$46.40
Total Value
$928.00K
Shares Held After
148,235
% of Holdings
11.9%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
10,000
Price
$46.46
Total Value
$464.60K
Shares Held After
168,235
% of Holdings
5.6%
Ridgetech Inc. (RDGT)
HRT FINANCIAL LP — 10% Owner
Shares
30,939
Price
$1.52
Total Value
$47.03K
Shares Held After
90,302
% of Holdings
34.3%
Aveanna Healthcare Holdings, Inc. (AVAH)
VIGANO PAUL R — 10% Owner
Shares
55,121
Price
$8.01
Total Value
$441.52K
Shares Held After
190,130
% of Holdings
22.5%
Aveanna Healthcare Holdings, Inc. (AVAH)
VIGANO PAUL R — 10% Owner
Shares
525,844
Price
$8.01
Total Value
$4.21M
Shares Held After
1,813,795
% of Holdings
22.5%
Aveanna Healthcare Holdings, Inc. (AVAH)
VIGANO PAUL R — 10% Owner
Shares
2,419,035
Price
$8.01
Total Value
$19.38M
Shares Held After
10,112,123
% of Holdings
19.3%
Aveanna Healthcare Holdings, Inc. (AVAH)
WILLIAMS ROBERT M JR — 10% Owner
Shares
55,121
Price
$8.01
Total Value
$441.52K
Shares Held After
190,130
% of Holdings
22.5%
Aveanna Healthcare Holdings, Inc. (AVAH)
WILLIAMS ROBERT M JR — 10% Owner
Shares
525,844
Price
$8.01
Total Value
$4.21M
Shares Held After
1,813,795
% of Holdings
22.5%
Aveanna Healthcare Holdings, Inc. (AVAH)
WILLIAMS ROBERT M JR — 10% Owner
Shares
2,419,035
Price
$8.01
Total Value
$19.38M
Shares Held After
10,112,123
% of Holdings
19.3%
Aveanna Healthcare Holdings, Inc. (AVAH)
J.H. Whitney Equity Partners VII, LLC — 10% Owner
Shares
2,419,035
Price
$8.01
Total Value
$19.38M
Shares Held After
10,112,123
% of Holdings
19.3%
Ceribell, Inc. (CBLL)
BURKE WILLIAM W — Director
Shares
2,207
Price
$19.84
Total Value
$43.79K
Shares Held After
23,022
% of Holdings
8.7%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
4,255
Price
$24.98
Total Value
$106.29K
Shares Held After
41,688
% of Holdings
10.2%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,638
Price
$23.88
Total Value
$39.12K
Shares Held After
37,433
% of Holdings
4.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,910
Price
$22.95
Total Value
$43.83K
Shares Held After
35,795
% of Holdings
5.3%
Theravance Biopharma, Inc. (TBPH)
Samaha Eli — 10% Owner
Shares
25,027
Price
$17.13
Total Value
$428.79K
Shares Held After
9,212,252
% of Holdings
0.3%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
HRT FINANCIAL LP — 10% Owner
Shares
6,755
Price
$3.23
Total Value
$21.82K
Shares Held After
78,597
% of Holdings
8.6%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
30,703
Price
$35.49
Total Value
$1.09M
Shares Held After
93,969
% of Holdings
24.6%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
27,872
Price
$35.48
Total Value
$988.89K
Shares Held After
58,750
% of Holdings
32.2%
Contineum Therapeutics, Inc. (CTNM)
Watkins Tim — CMO & Head of Development
Shares
10,833
Price
$16.02
Total Value
$173.59K
Shares Held After
8,961
% of Holdings
54.7%
Contineum Therapeutics, Inc. (CTNM)
Stengone Carmine N. — Director
Shares
10,000
Price
$16.01
Total Value
$160.08K
Shares Held After
17,217
% of Holdings
36.7%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
30,712
Price
$35.49
Total Value
$1.09M
Shares Held After
315,167
% of Holdings
8.9%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
200
Price
$6.30
Total Value
$1.26K
Shares Held After
3,581,293
% of Holdings
0.0%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
19,650
Price
$6.02
Total Value
$118.32K
Shares Held After
3,581,493
% of Holdings
0.5%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
45,419
Price
$6.14
Total Value
$279.05K
Shares Held After
3,601,143
% of Holdings
1.2%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
172
Price
$35.00
Total Value
$6.02K
Shares Held After
55,285
% of Holdings
0.3%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
1,900
Price
$34.84
Total Value
$66.20K
Shares Held After
1,047,205
% of Holdings
0.2%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
23,100
Price
$34.26
Total Value
$791.48K
Shares Held After
1,049,105
% of Holdings
2.2%
Showing 151–200 of 508 transactions (page 4 of 11)